MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6

被引:104
作者
Shao, Yuan [1 ]
Qu, Yiping [2 ]
Dang, Siwen [2 ]
Yao, Bowen [3 ]
Ji, Meiju [4 ]
机构
[1] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Otolaryngol, Xian 710061, Peoples R China
[2] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Endocrinol, Xian 710061, Peoples R China
[3] Xi An Jiao Tong Univ, Sch Med, Dept Clin Med, Xian 710061, Peoples R China
[4] First Affiliated Hosp Xian Jiaotong, Ctr Translat Med, Xian 710061, Peoples R China
基金
中国国家自然科学基金;
关键词
Oral squamous cell carcinoma (OSCC); MiR-145; c-Myc; Cyclin D1; Cdk6; MICRORNA SIGNATURES; TUMOR SUPPRESSORS; CANCER; EXPRESSION; METHYLATION; AND-145; CLUSTER; GENES; DEATH; RNAS;
D O I
10.1186/1475-2867-13-51
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: MicroRNAs (miRNAs) are a large group of negative gene regulators that potentially play a critical role in tumorigenesis. Increasing evidences indicate that miR-145 acts a tumor suppressor in numerous human cancers. However, its role in oral carcinogenesis remains poorly defined. The aim of this study is to determine expression levels of miR-145 in oral squamous cell carcinomas (OSCCs) and normal mucosa tissues, and explore its biological functions in OSCCs. Methods: Reverse transcription quantitative real-time PCR (RT-qPCR) assay was used to evaluate expression levels of miR-145. The biological functions of miR-145 were determined by cell proliferation and colony formation, cell cycle and apoptosis, as well as cell invasion assay. Results: MiR-145 was frequently down-regulated in OSCCs compared with normal mucosa tissues. Restoring miR-145 expression in OSCC cells dramatically suppressed cell proliferation and colony formation, and induced G1 phase arrest and cell apoptosis. Importantly, our data showed that miR-145 downregulated the expression of c-Myc and Cdk6, which have previously been identified as two direct targets of miR-145. Conclusions: Our data suggest that miR-145 exerts its tumor suppressor function by targeting c-Myc and Cdk6, leading to the inhibition of OSCC cell growth. MiR-145 rescue may thus be a rational for diagnostic and therapeutic applications in OSCC.
引用
收藏
页数:9
相关论文
共 40 条
[1]   Downregulation of microRNAs-143 and-145 in B-cell malignancies [J].
Akao, Yukihiro ;
Nakagawa, Yoshihito ;
Kitade, Yukio ;
Kinoshita, Tomohiro ;
Naoe, Tomoki .
CANCER SCIENCE, 2007, 98 (12) :1914-1920
[2]   MicroRNA-143 and-145 in colon cancer [J].
Akao, Yukihiro ;
Nakagawa, Yoshihito ;
Naoe, Tomoki .
DNA AND CELL BIOLOGY, 2007, 26 (05) :311-320
[3]   microRNAs: Tiny regulators with great potential [J].
Ambros, V .
CELL, 2001, 107 (07) :823-826
[4]  
Júnior RFDA, 2008, MED ORAL PATOL ORAL, V13, pE344
[5]   MicroRNA signatures in human cancers [J].
Calin, George A. ;
Croce, Carlo M. .
NATURE REVIEWS CANCER, 2006, 6 (11) :857-866
[6]   miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc [J].
Chen, Zhe ;
Zeng, Huazong ;
Guo, Yong ;
Liu, Pei ;
Pan, Hui ;
Deng, Anmei ;
Hu, Jian .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2010, 29
[7]   miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer [J].
Chiyomaru, T. ;
Enokida, H. ;
Tatarano, S. ;
Kawahara, K. ;
Uchida, Y. ;
Nishiyama, K. ;
Fujimura, L. ;
Kikkawa, N. ;
Seki, N. ;
Nakagawa, M. .
BRITISH JOURNAL OF CANCER, 2010, 102 (05) :883-891
[8]   miR-145 and miR-143 regulate smooth muscle cell fate and plasticity [J].
Cordes, Kimberly R. ;
Sheehy, Neil T. ;
White, Mark P. ;
Berry, Emily C. ;
Morton, Sarah U. ;
Muth, Alecia N. ;
Lee, Ting-Hein ;
Miano, Joseph M. ;
Ivey, Kathryn N. ;
Srivastava, Deepak .
NATURE, 2009, 460 (7256) :705-U80
[9]  
Dang CV, 1999, MOL CELL BIOL, V19, P1
[10]   c-Myc Oncoprotein Cell Cycle-Related Events and New Therapeutic Challenges in Cancer and Cardiovascular Diseases [J].
de Nigris, Filomena ;
Sica, Vincenzo ;
Herrmann, Joerg ;
Condorelli, Gianluigi ;
Chade, Alejandro R. ;
Tajana, Gianfranco ;
Lerman, Amir ;
Lerman, Lilach O. ;
Napoli, Claudio .
CELL CYCLE, 2003, 2 (04) :325-328